Aptevo TherapeuticsAPVO
13F holders, Q4 2025 (December 31)11holders
$9.43avg. 13F price*
At the end of Q4 2025, 11 institutions reported holding Aptevo Therapeutics Inc. (APVO) in their 13F filings. The largest holders were Vanguard Group Inc. ($159K), Citigroup Inc. ($26K) and Osaic Holdings, Inc. ($3K).
- Company
- Aptevo Therapeutics Inc.
- CUSIP
- 03835L702
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $191K |
| Exits | 0 | $0 |
Ownership 11 holders
| Vanguard Group Inc. | 0.00% | New | 16,856 | $159K |
| Citigroup Inc. | 0.00% | New | 2,756 | $26K |
| Osaic Holdings, Inc. | 0.00% | New | 360 | $3K |
| UBS Group AG | 0.00% | New | 170 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 92 | $868 |
| SBI Securities Co., Ltd. | 0.00% | New | 31 | $292 |
| Tradewinds Capital Management, LLC | 0.00% | New | 13 | $118 |
| Bank of America Corp. | 0.00% | New | 7 | $66 |
| FMR LLC | 0.00% | New | 7 | $66 |
| Danske Bank A/S | 0.00% | New | 1 | $9 |
| Cwm, LLC | 0.00% | New | 6 | $0 |
"% of holder's portfolio" is APVO's weight in each manager's 13F, not the share of Aptevo Therapeutics Inc. the manager owns.